1435 related articles for article (PubMed ID: 23835018)
1. Evidence of endogenous volatile organic compounds as biomarkers of diseases in alveolar breath.
Sarbach C; Stevens P; Whiting J; Puget P; Humbert M; Cohen-Kaminsky S; Postaire E
Ann Pharm Fr; 2013 Jul; 71(4):203-15. PubMed ID: 23835018
[TBL] [Abstract][Full Text] [Related]
2. Evidence of variations of endogenous halogenated volatile organic compounds in alveolar breath after mental exercise-induced oxidative stress.
Sarbach C; Dugas B; Postaire E
Ann Pharm Fr; 2020 Jan; 78(1):34-41. PubMed ID: 31796267
[TBL] [Abstract][Full Text] [Related]
3. Volatile biomarkers of pulmonary tuberculosis in the breath.
Phillips M; Cataneo RN; Condos R; Ring Erickson GA; Greenberg J; La Bombardi V; Munawar MI; Tietje O
Tuberculosis (Edinb); 2007 Jan; 87(1):44-52. PubMed ID: 16635588
[TBL] [Abstract][Full Text] [Related]
4. Breath biomarkers of whole-body gamma irradiation in the Göttingen minipig.
Phillips M; Cataneo RN; Chaturvedi A; Kaplan PD; Libardoni M; Mundada M; Patel U; Thrall KD; Zhang X
Health Phys; 2015 May; 108(5):538-46. PubMed ID: 25811151
[TBL] [Abstract][Full Text] [Related]
5. Method for the collection and assay of volatile organic compounds in breath.
Phillips M
Anal Biochem; 1997 May; 247(2):272-8. PubMed ID: 9177688
[TBL] [Abstract][Full Text] [Related]
6. Detection of an extended human volatome with comprehensive two-dimensional gas chromatography time-of-flight mass spectrometry.
Phillips M; Cataneo RN; Chaturvedi A; Kaplan PD; Libardoni M; Mundada M; Patel U; Zhang X
PLoS One; 2013; 8(9):e75274. PubMed ID: 24086492
[TBL] [Abstract][Full Text] [Related]
7. Automated needle trap heart-cut GC/MS and needle trap comprehensive two-dimensional GC/TOF-MS for breath gas analysis in the clinical environment.
Mieth M; Schubert JK; Gröger T; Sabel B; Kischkel S; Fuchs P; Hein D; Zimmermann R; Miekisch W
Anal Chem; 2010 Mar; 82(6):2541-51. PubMed ID: 20170082
[TBL] [Abstract][Full Text] [Related]
8. Ion mobility spectrometry for the detection of volatile organic compounds in exhaled breath of patients with lung cancer: results of a pilot study.
Westhoff M; Litterst P; Freitag L; Urfer W; Bader S; Baumbach JI
Thorax; 2009 Sep; 64(9):744-8. PubMed ID: 19158121
[TBL] [Abstract][Full Text] [Related]
9. Volatile organic compounds (VOCs) in exhaled breath of patients with breast cancer in a clinical setting.
Mangler M; Freitag C; Lanowska M; Staeck O; Schneider A; Speiser D
Ginekol Pol; 2012 Oct; 83(10):730-6. PubMed ID: 23383557
[TBL] [Abstract][Full Text] [Related]
10. Proton transfer reaction-mass spectrometry applications in medical research.
Herbig J; Amann A
J Breath Res; 2009 Jun; 3(2):020201. PubMed ID: 21383455
[TBL] [Abstract][Full Text] [Related]
11. Experimental setup and analytical methods for the non-invasive determination of volatile organic compounds, formaldehyde and NOx in exhaled human breath.
Riess U; Tegtbur U; Fauck C; Fuhrmann F; Markewitz D; Salthammer T
Anal Chim Acta; 2010 Jun; 669(1-2):53-62. PubMed ID: 20510903
[TBL] [Abstract][Full Text] [Related]
12. Human exhaled air analytics: biomarkers of diseases.
Buszewski B; Kesy M; Ligor T; Amann A
Biomed Chromatogr; 2007 Jun; 21(6):553-66. PubMed ID: 17431933
[TBL] [Abstract][Full Text] [Related]
13. Pilot study of a breath test for volatile organic compounds associated with oral malodor: evidence for the role of oxidative stress.
Phillips M; Cataneo RN; Greenberg J; Munawar M; Nachnani S; Samtani S
Oral Dis; 2005; 11 Suppl 1():32-4. PubMed ID: 15752095
[TBL] [Abstract][Full Text] [Related]
14. Quantitative breath analysis of volatile organic compounds of lung cancer patients.
Song G; Qin T; Liu H; Xu GB; Pan YY; Xiong FX; Gu KS; Sun GP; Chen ZD
Lung Cancer; 2010 Feb; 67(2):227-31. PubMed ID: 19409642
[TBL] [Abstract][Full Text] [Related]
15. Analysis of volatile organic compounds in exhaled breath by gas chromatography-mass spectrometry combined with chemometric analysis.
Dallinga JW; Smolinska A; van Schooten FJ
Methods Mol Biol; 2014; 1198():251-63. PubMed ID: 25270934
[TBL] [Abstract][Full Text] [Related]
16. Detection of potential chronic kidney disease markers in breath using gas chromatography with mass-spectral detection coupled with thermal desorption method.
Grabowska-Polanowska B; Faber J; Skowron M; Miarka P; Pietrzycka A; Sliwka I; Amann A
J Chromatogr A; 2013 Aug; 1301():179-89. PubMed ID: 23764192
[TBL] [Abstract][Full Text] [Related]
17. Alveolar air volatile organic compound extractor for clinical breath sampling.
de Silva G; Beyette FR
Annu Int Conf IEEE Eng Med Biol Soc; 2014; 2014():5369-72. PubMed ID: 25571207
[TBL] [Abstract][Full Text] [Related]
18. Point-of-care breath test for biomarkers of active pulmonary tuberculosis.
Phillips M; Basa-Dalay V; Blais J; Bothamley G; Chaturvedi A; Modi KD; Pandya M; Natividad MP; Patel U; Ramraje NN; Schmitt P; Udwadia ZF
Tuberculosis (Edinb); 2012 Jul; 92(4):314-20. PubMed ID: 22647661
[TBL] [Abstract][Full Text] [Related]
19. The versatile use of exhaled volatile organic compounds in human health and disease.
Boots AW; van Berkel JJ; Dallinga JW; Smolinska A; Wouters EF; van Schooten FJ
J Breath Res; 2012 Jun; 6(2):027108. PubMed ID: 22621865
[TBL] [Abstract][Full Text] [Related]
20. A profile of volatile organic compounds in breath discriminates COPD patients from controls.
Van Berkel JJ; Dallinga JW; Möller GM; Godschalk RW; Moonen EJ; Wouters EF; Van Schooten FJ
Respir Med; 2010 Apr; 104(4):557-63. PubMed ID: 19906520
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
